Zimmer Biomet Reports Q2 2026 Results
Zimmer Biomet reported Q2 revenue growth of 4.8% and updated full-year 2026 guidance to reflect solid performance, while also increasing its share repurchase expectations to $1 billion.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day